ArticleLaboratory investigation; a journal of technical methods and pathology2025
Comparison of QuPath and HALO Platforms for Analysis of the Tumor Microenvironment in Prostate Cancer.
Article in Laboratory investigation; a journal of technical methods and pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Assessment of CD3+ T cell density in the intestinal mucosa of dogs with inflammatory bowel disease.Journal of veterinary internal medicine · 2026Article
- Review
- Comprehensive Overview of Gastric Cancer Immunohistochemistry: Key Biomarkers, Advanced Detection Methods, and Perspectives.Medicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
- Update of
Authors and funding
10 authors.
Funding
Abstract
QuPath, an open-source digital pathology platform, has gained widespread use for image analysis in biomedical research since its release in 2016. However, its reproducibility and reliability compared with commercial software, such as HALO, require further validation, particularly for multiplex immunofluorescence analysis. In this study, we performed a direct comparison of QuPath and HALO using a multiplex immunofluorescence-stained prostate cancer tissue microarray inclusive of 192 unique cores. We evaluated performance across 3 key analytical modules: immune cell phenotyping, tumor infiltration with immune cells, and nearest neighbor analysis. Furthermore, we integrated QuPath with CytoMap, an open-source spatial analysis tool, to perform unsupervised clustering of immune cell infiltration-a feature not available in HALO. Our results demonstrated high concordance between 2 platforms, with correlation coefficients >0.89 for immune cell density, distance, and pattern of cell organization in tumor microenvironment. A neighborhood analysis using CytoMap was further performed and provided a more detailed spatial analysis of immune cell distribution across different prostate cancer grades. A significant increase of CD103+ T-cell infiltration into tumor microenvironment was observed in prostate cancer. In conclusion, our findings validate QuPath as a robust and reproducible alternative to commercial platforms for fluorescence-based digital pathology. By demonstrating QuPath's capability to perform high-quality quantitative analysis with additional flexibility for integration with external tools, our study underscores its potential for advancing tumor microenvironment research in translational oncology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.